Hematopoetic Stem Cell Transplant

Hematopoietic stem cells in the blood that may have many other applications to treat more than just cancers of the blood. Our team uses hematopoietic stem cell transplant clinical trials to find faster and more personalized tactics solutions for multiple different kinds of cancers throughout the body.

Haploidentical Hematopoietic Cell Transplant for Children with Hematologic Malignancies and Myelodysplasia

Protocol ID: HapLeuk17

Disease: HSCT

Who can participate?: Patient must be less than 31 years of age at the time of initial diagnosis of ALL

Lead Researcher: Mark A. Ranalli, MD

An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

Protocol ID: CMX001-351

Disease: Adenovirus

Who can participate?: Male or female, aged 2 months and older

Lead Researcher: Hema

Host Defense Program Hematopoietic Cell Transplant Data Repository

Protocol ID: HOST Defense Repository

Disease: HSCT

Who can participate?: Any pediatric patient undergoing autologous or allogeneic hematopoietic cell transplantation is eligible

Lead Researcher: Jeffery J. Auletta, MD

Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Protocol ID: NMDP/Data Collection

Disease: HSCT

Who can participate?: Any recipient of an unrelated or related donor or autologous HC transplant or any recipient of cellular therapy in a CIBMTR center is eligible to participate in the Research Database

Lead Researcher: Jeffery J. Auletta, MD

Protocol for a Research Sample Repository for Allogeneic Hematopoietic Cell Transplantation and Marrow Toxic Injuries

Protocol ID: NMDP/Sample Repository

Disease: HSCT

Who can participate?: No specific age requirement

Lead Researcher: Jeffery J. Auletta, MD

Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients

Protocol ID: 

Disease: HSCT

Who can participate?: 3 - 17 years of age

Lead Researcher: Monica I. Ardura, DO

Allogeneic Hematopoietic Stem Cell Transplant Tissue Bank (ATTB)

Protocol ID: ATTB

Disease: HSCT

Who can participate?:

Lead Researcher: Jeffery J. Auletta, MD

Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients with Suspected Lower Respiratory Tract Infection

Protocol ID: PBMTC SUP1601

Disease: HSCT

Who can participate?: Patients will be ≤21 years of age with a history of HCT

Lead Researcher: Rajinder P. Bajwa, MD

Impact of T and NK cell immune reconstitution on human Adenovirus (HAdV) infection in pediatric patients with allogeneic hematopoietic stem cell transplantation (HSCT)

Protocol ID: Adenovirus immune constitution study

Disease: HSCT

Who can participate?: Patients from 6 months to 18 years old who receive an allogenic HSCT at NCH

Lead Researcher: Eunkyung Song, MD

CHOP HAdV: Outcomes of Human Adenovirus (HAdV) Infection and Disease in Pediatric Allogeneic Stem Cell Transplant Recipients: A Prospective Multicenter Observational Cohort

Protocol ID: CHOP HAdV

Disease: Adenovirus

Who can participate?: Age less than 18 years of age at the time of transplant

Lead Researcher: Monica I. Ardura, DO